Kratom’s primary alkaloid, mitragynine, has a half-life of approximately 9 hours in humans — meaning the amount in your bloodstream halves every 9 hours. By that measure, mitragynine is largely cleared from blood within 2–3 days for most users. However, metabolites persist in urine substantially longer, and daily use causes accumulation that significantly extends both effects and detection windows. This guide covers the pharmacokinetics behind how long kratom stays in your system, what factors speed or slow clearance, and what detection windows actually look like by test type.
What Happens to Kratom in Your Body After You Take It?
After oral ingestion, kratom alkaloids are absorbed through the gastrointestinal tract and enter systemic circulation. Mitragynine — the primary alkaloid, typically comprising 60–70% of the total alkaloid content — is then metabolized primarily by cytochrome P450 enzymes in the liver, particularly CYP3A4 and CYP2D6.[1]
The metabolic process converts mitragynine into several metabolites, some of which retain pharmacological activity. Key metabolites identified in human urine include mitragynine pseudoindoxyl and 7-hydroxymitragynine — the latter being the most potent alkaloid present in kratom leaves, though it occurs at much lower concentrations than mitragynine.[2]
These metabolites are excreted primarily in urine, which is why urine testing is the most practical method for detecting past kratom use. The parent compound (mitragynine) tends to clear from blood relatively quickly after the last dose, while metabolites persist in urine for a significantly longer window — which is the pharmacokinetic basis for detection windows being substantially longer than the duration of effects.

What Does Mitragynine’s Half-Life Tell Us About Clearance?
The foundational pharmacokinetic data for kratom clearance comes from Trakulsrichai et al. (2015), who conducted the first pharmacokinetic study of mitragynine in humans following single oral doses. They established a mean elimination half-life of approximately 9.04 hours (range: 8.0–10.2 hours across subjects) after a controlled oral dose.[3]
Half-life is the time required for the concentration of a substance in the body to decrease by 50%. Using the 9-hour half-life:
| Time Since Dose | Approximate % Remaining in Blood | Half-Lives Elapsed |
|---|---|---|
| 9 hours | ~50% | 1 |
| 18 hours | ~25% | 2 |
| 27 hours | ~12.5% | 3 |
| 36 hours | ~6% | 4 |
| 45 hours (~2 days) | ~3% — trace levels | 5 — practical clearance threshold |
| 54 hours (~2.25 days) | <2% — functionally cleared | 6 |
The clinical pharmacokinetic study by Tanna et al. (2022) — the first controlled human PK study using commercial kratom products with verified alkaloid content — confirmed multi-day clearance timelines and further characterized the variability between individuals, including Cmax, Tmax, and AUC parameters that establish clearance benchmarks for clinical reference.[4] This inter-individual variability means the 9-hour half-life is a mean, not a fixed value: slower metabolizers (those with less active CYP enzyme variants) will clear mitragynine more slowly than faster metabolizers. Sempio et al. (2025) in Analytical and Bioanalytical Chemistry pushed the analytical frame further, quantifying 11 kratom alkaloids — mitragynine plus major metabolites and minor alkaloids such as speciociliatine and paynantheine — in human plasma by LC-MS/MS, and the multi-alkaloid profile showed that several compounds follow distinct elimination trajectories from mitragynine itself.[6] That matters for detection: a blood draw after a single dose won’t look like a single half-life curve, it looks like a family of them.
Important caveat: The 9-hour half-life applies to the parent compound (mitragynine) in blood. Metabolites excreted in urine follow a different timeline. Urine detection windows can be substantially longer than blood clearance, because metabolites continue to be excreted after the parent compound has largely cleared from circulation.
How Long Does Kratom Stay Detectable by Test Type?
Detection windows vary considerably by the type of biological specimen tested. Standard drug tests do not screen for kratom — this section addresses what specialized kratom-specific testing would detect, which is relevant in legal, forensic, and clinical contexts.
| Test Type | Occasional Users (≤2x/week) | Daily Users | Detection Target |
|---|---|---|---|
| Urine | 1–3 days | 5–9 days | Mitragynine + metabolites |
| Blood / Plasma | 12–24 hours | 24–48 hours | Mitragynine (parent compound) |
| Saliva | Up to 24 hours | Up to 48 hours | Mitragynine (limited data) |
| Hair Follicle | Up to 90 days (estimated) | Up to 90 days | Mitragynine incorporated into hair shaft (limited clinical data) |
Why urine has a longer window than blood: After mitragynine clears from plasma (2–3 days for occasional users), its metabolites continue to be excreted into urine. The urine metabolites identified by Philipp et al. (2010) include several phase I and II metabolic products — these are what sensitive kratom-specific urine tests actually detect.[2] Helander et al. (2023) in Drug Testing and Analysis reviewed the current state of kratom-specific drug testing and its analytical and medico-legal pitfalls — including the absence of mitragynine from standard immunoassay panels, variable cutoffs across labs, and the chain-of-custody issues that arise when a positive for kratom is used in employment or custody contexts.[7] The practical takeaway: “does kratom show up on a drug test” depends heavily on which test and which lab — not on a universal detection window.
Hair follicle caveat: Kratom-specific hair testing is not commercially routine. Hair follicle tests for most substances use a standard 1.5-inch hair sample, corresponding to approximately 90 days of growth. While mitragynine can theoretically be incorporated into hair keratin during growth, published clinical data on kratom hair detection windows is limited. Rhee et al. (2024) in the Journal of Analytical Toxicology is among the first to apply LC-MS/MS detection of mitragynine and 7-HMG to authentic hair samples from suspected kratom users and confirmed that both compounds do incorporate into the hair shaft at detectable levels — establishing that hair testing for kratom is technically feasible, while also noting the quantitative limits that still need method standardization.[8] The 90-day figure applies to hair tests generally; kratom-specific hair testing sensitivity varies by laboratory.
For questions specifically about employer drug testing and whether kratom shows up on standard panels, see our Kratom Drug Test Guide.
What Factors Affect How Long Kratom Stays in Your System?
Several variables significantly influence how long mitragynine and its metabolites remain detectable:
- Frequency and dose of use — the most significant factor. Daily use at higher doses leads to accumulation (see section below). A single moderate dose clears in 2–3 days from blood; daily use over months means clearance takes substantially longer after the last dose.
- Metabolizer status (CYP enzyme variants) — CYP3A4 and CYP2D6 activity varies genetically. Poor metabolizers (certain CYP2D6 genetic variants) eliminate mitragynine more slowly. Hanapi et al. (2013) documented mitragynine’s inhibitory activity on CYP enzymes — this matters particularly for users taking other medications that compete for the same pathways.[1]
- Body composition — mitragynine is lipophilic (fat-soluble, LogP ~2.9). Fat-soluble compounds tend to accumulate in adipose tissue and release more slowly. Individuals with higher body fat percentage may clear mitragynine more slowly than leaner individuals at the same dose.
- Liver function — hepatic impairment reduces the liver’s capacity to metabolize mitragynine via CYP enzymes, slowing clearance. Significant liver disease can meaningfully extend clearance timelines.
- Hydration and kidney function — adequate hydration supports urinary excretion of metabolites. Dehydration slows elimination; compromised kidney function reduces excretory capacity.
- Age — CYP enzyme activity declines with age in most individuals, meaning older adults tend to metabolize kratom more slowly than younger adults at the same dose.
- Concurrent medications — drugs that inhibit CYP3A4 (certain antifungals, some antibiotics) can dramatically slow mitragynine clearance; CYP3A4 inducers (rifampin, certain anticonvulsants) can accelerate it.

How Does System Clearance Differ From How Long Effects Last?
This is the most important conceptual distinction on this page. Effects and detectability are two separate timelines, and confusing them leads to incorrect assumptions in both directions.
Kratom’s subjective effects — the felt changes in energy, mood, or discomfort — are driven by mitragynine’s active binding to receptors. Once plasma concentrations fall below the threshold for noticeable receptor activation (roughly 30–60% of peak levels), effects wear off. This typically happens within 3–6 hours of a standard dose for most users.
Detectability, by contrast, depends on the analytical sensitivity of the test — not on receptor activation. A test that can detect mitragynine at 10 ng/mL can still flag a sample long after the user no longer feels any effects. Conversely, detection at a low level does not mean the user is impaired or that the substance is still active pharmacologically.
For practical reference:
- Effects from a moderate dose typically resolve within 3–6 hours
- Mitragynine clears from blood within 24–48 hours (occasional users)
- Urinary metabolites may remain detectable for 5–9 days in daily users
The Kruegel and Grundmann (2018) review of kratom’s medicinal chemistry and neuropharmacology documents the pharmacokinetic basis for this effects/detectability distinction — mitragynine’s binding kinetics drive effect duration, while its metabolic fate determines detection windows.[5]
If you are looking for how long kratom’s effects last rather than how long it stays in your system, see our How Long Does Kratom Last? guide.
Does Kratom Build Up in Your System With Daily Use?
Yes — and this is one of the most practically important aspects of kratom pharmacokinetics for regular users to understand.
With a 9-hour half-life, a dose taken at 8 AM still has ~25% of peak concentration at midnight (2 half-lives). If the user takes another dose the next morning before the first has fully cleared, the second dose adds to a residual baseline. Over multiple days of daily dosing, the system reaches a steady-state concentration — a plateau where each day’s dose partially overlaps with residual from the previous day.
Steady-state accumulation means:
- The effective concentration the body is exposed to each day is higher than any single dose alone would produce
- The threshold for effects may shift upward over time (tolerance) as the body adapts to this sustained receptor activation
- After stopping daily use, clearance does not happen in 2–3 days as it would for a single use — the accumulated residual requires additional time to clear, extending both the window of physiological effects and the detection window
Practically: a daily kratom user who stops on a Friday should not expect the same 2–3 day clearance as a first-time user. Depending on dose, duration of daily use, and individual metabolism, meaningful residual levels in a daily user can persist in urine for 7–10 days after the last dose. This is directly relevant to the question of tolerance break timing — the receptor system is still being exposed to declining but non-zero mitragynine levels for days after the last dose. The receptor upregulation that makes a tolerance break effective fully accelerates only after plasma and tissue levels approach zero. See our Kratom Tolerance Break Guide for the practical implications.
Frequently Asked Questions
How long does kratom stay in your urine?
For occasional users (1–2 times per week), kratom metabolites are typically detectable in urine for 1–3 days after the last use. For daily users, particularly those at higher doses over extended periods, mitragynine metabolites may remain detectable for 5–9 days. Heavy, chronic users at very high doses could theoretically see detection beyond 9 days. These windows apply to specialized kratom-specific urine tests — standard workplace urine drug screens do not test for kratom and would not detect it regardless of how recently it was used.
How long does kratom stay in your blood?
Blood clearance is faster than urine. Based on the 9-hour half-life established by Trakulsrichai et al. (2015),[3] mitragynine falls to trace levels in blood within 24–48 hours for occasional users. Blood tests have a short detection window precisely because they measure the parent compound directly — once it’s metabolized, it’s no longer detectable in blood. Blood testing for kratom is primarily used in clinical or forensic contexts, not routine workplace screening.
Does kratom show up on a standard 5-panel or 10-panel drug test?
No. Standard 5-panel and 10-panel drug tests screen for specific substances (THC metabolites, cocaine, amphetamines, opiates/opioids, PCP, and others depending on the panel). Kratom alkaloids are not included in these standard panels and are chemically distinct from the substances tested. Kratom does not cause a false positive on standard opioid panels — its alkaloids are structurally different from morphine, codeine, or synthetic opioids that standard immunoassay tests target. See our full Kratom Drug Test Guide for a detailed breakdown by test type.
How long after stopping kratom will I feel normal?
This question is about pharmacological effects and any adjustment symptoms, not chemical detection. For occasional users at moderate doses, kratom effects resolve within 3–6 hours of the last dose, and there are typically no lingering adjustment effects. For daily users, the first 2–4 days after stopping often involve mild adjustment (low energy, disrupted sleep, irritability) as the body recalibrates without the sustained receptor activation kratom was providing. By days 4–7, most moderate daily users report returning to baseline. This timeline is separate from chemical detectability — you may feel normal well before all metabolites have cleared from your urine.
Does drinking water help flush kratom from your system faster?
Staying well-hydrated supports healthy kidney function and urinary excretion of metabolites, which can mildly support clearance. However, drinking excessive water does not dramatically accelerate mitragynine elimination — the rate-limiting step is liver metabolism via CYP enzymes, not urinary output. Attempting to dilute urine with excessive fluid intake before a drug test is not an effective strategy and may flag as specimen adulteration (low creatinine levels) on a supervised test. The honest answer is that normal healthy hydration is good for clearance; excessive water consumption has no meaningful pharmacokinetic benefit beyond that.
Does kratom stay in system longer for heavier people?
Body composition plays a role because mitragynine is fat-soluble. Fat-soluble compounds can accumulate in adipose tissue, creating a secondary reservoir that releases slowly as plasma levels fall. In practice, this effect is relatively modest for kratom compared to highly lipophilic compounds like THC, but it does mean that individuals with higher body fat may clear mitragynine somewhat more slowly. Dose and frequency of use are still much larger determinants of clearance time than body composition for most people.
How long should I wait after stopping kratom before a drug test?
For standard workplace drug tests that don’t screen for kratom: this question is effectively moot — you will not test positive regardless of recent use. If you are facing a test that specifically includes kratom (certain forensic, legal, or clinical panels): the conservative answer for a daily user is at least 10 days from the last dose; for occasional users, 5–7 days is generally sufficient for urine clearance. Individual factors can shift these windows substantially — slower metabolizers and those with liver or kidney impairment should add additional buffer. If you are uncertain about what a specific test screens for, ask the administering lab directly.
Does exercise speed up kratom metabolism?
Cardiovascular exercise increases overall metabolic rate and blood flow to the liver, which can mildly support clearance. More relevantly, exercise mobilizes fat stores — for fat-soluble compounds, this can temporarily increase the release of accumulated alkaloids from adipose tissue back into circulation before they are metabolized. The net effect on kratom clearance is modest. Exercise is genuinely good for the adjustment period after stopping kratom (it helps with low energy and mood), but it is not a significant accelerant of chemical clearance.
References
- Hanapi NA, Ismail S, Mansor SM. (2013). Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities. Pharmacognosy Research. [PubMed]
- Philipp AA (2011). Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology. Analytical and bioanalytical chemistry. [PubMed]
- Trakulsrichai S, Sathirakul K, Auparppong S et al. (2015). Pharmacokinetics of mitragynine in man. Drug Design, Development and Therapy. [PubMed]
- Tanna RS, Nguyen JT, Hadi DL et al. (2022). Clinical pharmacokinetic assessment of kratom (Mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants. Clinical Pharmacology & Therapeutics. [PubMed]
- Kruegel AC, Grundmann O. (2018). The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. [PubMed]
- Sempio C, et al. (2025). Quantification of 11 kratom alkaloids including mitragynine and its main metabolites in human plasma using LC-MS/MS. Analytical and Bioanalytical Chemistry. [PubMed]
- Helander A, et al. (2023). Drug testing for mitragynine and kratom: analytical challenges and medico-legal considerations. Drug Testing and Analysis. [PubMed]
- Rhee J, et al. (2024). LC-MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers. Journal of Analytical Toxicology. [PubMed]
Disclaimer: This article is for educational purposes only and is not medical advice. Kratom is not FDA-approved to diagnose, manage, resolve, or prevent any condition. Detection windows described herein are estimates based on pharmacokinetic principles and available literature — individual results vary. Consult a qualified healthcare provider with specific health or legal questions.
Browse our COA-verified kratom.
← Back to Learning CenterShop Lab-Tested Kratom
Browse our full selection of AKA GMP-qualified kratom — powder, capsules, extracts, and more. Free shipping on orders $99+.
Shop All Kratom